Zhengye Biotechnology Holding
ZYBT
10 hedge funds and large institutions have $416K invested in Zhengye Biotechnology Holding in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
11% more funds holding
Funds holding: 9 → 10 (+1)
0.56% less ownership
Funds ownership: 0.89% → 0.34% (-0.56%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
83% less capital invested
Capital invested by funds: $2.51M → $416K (-$2.09M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$240K |
| 2 |
WG
Winton Group
London,
United Kingdom
|
+$149K |
| 3 |
Millennium Management
New York
|
+$101K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$81K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$1.16M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.04M |
| 3 |
Morgan Stanley
New York
|
-$2.96K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.69K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Invesco
Atlanta,
Georgia
| $95.5K | -$2.69K | -388 | -1% |
|
|
XT
2
XTX Topco
George Town,
Cayman Islands
| $90.6K | +$240K | +34,589 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $76.2K | – | – | – |
|
|
WG
4
Winton Group
London,
United Kingdom
| $56.5K | +$149K | +21,547 | New |
|
|
5
Millennium Management
New York
| $38.3K | +$101K | +14,602 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $30.6K | +$81K | +11,685 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $11.7K | +$7.8K | +1,126 | +34% |
|
|
8
UBS Group
Zurich,
Switzerland
| $11.3K | -$1.04M | -150,183 | -97% |
|
|
9
Morgan Stanley
New York
| $5.26K | -$2.96K | -427 | -18% |
|
|
CIAM
10
Caitong International Asset Management
Hong Kong
| $3 | +$7 | +1 | New |
|
|
11
Jane Street
New York
| – | -$1.16M | -193,982 | Closed |
|
|
12
BNP Paribas Financial Markets
Paris,
France
| – | -$1.56K | -262 | Closed |
|
13
Bank of America
Charlotte,
North Carolina
| – | -$436 | -73 | Closed |
|
ZYBT Hedge Fund Activity: Q3 2025 in Review
10 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Zhengye Biotechnology Holding (ZYBT) for Q3 2025, worth a combined $416K — down 83% from $2.51M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ZYBT positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $240K. The largest seller was Jane Street, exiting entirely with an estimated $1.16M sold.
- 10 institutional investors held Zhengye Biotechnology Holding (ZYBT) as of Q3 2025, up from 9 in Q2 2025.
- Funds reported $416K of Zhengye Biotechnology Holding stock for Q3 2025, down 83% quarter-over-quarter.
- 5 funds opened new Zhengye Biotechnology Holding positions in Q3 2025 and 4 closed out, a net change of +1 holder.
- The largest Zhengye Biotechnology Holding buyer in Q3 2025 was XTX Topco, an estimated $240K added.
- The largest Zhengye Biotechnology Holding seller in Q3 2025 was Jane Street, an estimated $1.16M sold.
Based on aggregated 13F filings for Q3 2025.